Personal information

No personal information available

Activities

Collapse all

Education and qualifications (3)

University of Kansas School of Medicine: Kansas City, KS, US

2021-07-01 to 2025-06-30 | Anesthesiology Resident Physician (Anesthesiology)
Education
Source: Self-asserted source
Kelsey Harder

University of Kansas School of Medicine: Kansas City, Kansas, US

2017-07 to 2021-05 | Doctor of Medicine (MD)
Education
Source: Self-asserted source
Kelsey Harder

University of Missouri Columbia: Columbia, MO, US

2013-08-19 to 2017-05 | Nutritional Sciences (Department of Nutrition and Exercise Physiology)
Education
Source: Self-asserted source
Kelsey Harder

Works (5)

Efficacy of an automated, temperature-controlled underbody water blanket for preventing perioperative hypothermia in neonatal intensive care unit surgical patients

Journal of Perinatology
2023-05 | Journal article
DOI: 10.1038/s41372-022-01465-8
Contributors: Kelsey N. Harder; Nicole R. Ost; Niaman Nazir; Jennifer K. Hansen
Source: check_circle
Crossref

Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.

ACS infectious diseases
2019-01-14 | Journal article
DOI: 10.1021/acsinfecdis.8b00235
PMID: 30582687
PMC: PMC6510658
Source: Self-asserted source
Kelsey Harder

5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors.

European journal of medicinal chemistry
2018-12-21 | Journal article
DOI: 10.1016/j.ejmech.2018.12.047
PMID: 30594676
PMC: PMC6362850
Source: Self-asserted source
Kelsey Harder

The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.

mSphere
2018-04-18 | Journal article
DOI: 10.1128/mspheredirect.00131-18
PMID: 29669885
PMC: PMC5907649
Source: Self-asserted source
Kelsey Harder

3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H.

Antimicrobial agents and chemotherapy
2017-05-24 | Journal article
DOI: 10.1128/aac.00245-17
PMID: 28320718
PMC: PMC5444124
Source: Self-asserted source
Kelsey Harder
How many people are using ORCID?